Overview
Caner Saygin is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois.
Dr. Saygin is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Bone Marrow Transplant.
Dr. Saygin is board certified in Hematology Medical Oncology Internal Medicine and Practicing Since2017. He is actively involved in clinical research, co-authoring 73 peer reviewed articles.
Residency
Specialties
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5758 S. Maryland Ave., Chicago, IL 60637
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
UChicago Medicine River East
Sonali Smith is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Smith is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Smith is board certified in Medical Oncology and Practicing Since2001.
Leo Gordon is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 53 years. Dr. Gordon is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Hodgkin Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Gordon is board certified in American Board Of Internal Medicine - Hematology (Certified).
Jessica Altman is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. She has been practicing medicine for over 25 years. Dr. Altman is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Altman is board certified in American Board Of Internal Medicine - Hematology (Certified).
Frequently Asked Questions about Dr. Caner Saygin
How do I make an appointment with Dr. Caner Saygin?
You can book an appointment with Dr. Caner Saygin by calling their office at 888-824-0200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Caner Saygin a top-rated expert for Acute Lymphoblastic Leukemia (ALL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Caner Saygin is classified as an Distinguished expert for Acute Lymphoblastic Leukemia (ALL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Caner Saygin specialize in?
While Dr. Caner Saygin is a Hematology, they have specific expertise in Acute Lymphoblastic Leukemia (ALL), Leukemia, and Acute Myeloid Leukemia (AML). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Caner Saygin participate in research or clinical trials?
Yes. Dr. Caner Saygin has published 73 articles and abstracts on conditions like Acute Lymphoblastic Leukemia (ALL). You can view a list of Dr. Caner Saygin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Caner Saygin accept my insurance?
Dr. Caner Saygin accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 888-824-0200 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Lymphoblastic Leukemia (ALL)Dr. Saygin isDistinguished. Learn about Acute Lymphoblastic Leukemia (ALL).
- LeukemiaDr. Saygin isDistinguished. Learn about Leukemia.
- Advanced
- Acute Myeloid Leukemia (AML)Dr. Saygin isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Myelodysplastic Syndrome (MDS)Dr. Saygin isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- Experienced
- AgranulocytosisDr. Saygin isExperienced. Learn about Agranulocytosis.
- B-Cell LymphomaDr. Saygin isExperienced. Learn about B-Cell Lymphoma.
- Bone Marrow TransplantDr. Saygin isExperienced. Learn about Bone Marrow Transplant.
- Chronic Myelomonocytic Leukemia (CMML)Dr. Saygin isExperienced. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Saygin isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Endometrial CancerDr. Saygin isExperienced. Learn about Endometrial Cancer.